Roivant Sciences (ROIV) Equity Average (2021 - 2025)
Historic Equity Average for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $4.9 billion.
- Roivant Sciences' Equity Average fell 1202.17% to $4.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.9 billion, marking a year-over-year decrease of 1202.17%. This contributed to the annual value of $5.4 billion for FY2025, which is 1772.37% down from last year.
- Per Roivant Sciences' latest filing, its Equity Average stood at $4.9 billion for Q4 2025, which was down 1202.17% from $4.8 billion recorded in Q3 2025.
- In the past 5 years, Roivant Sciences' Equity Average registered a high of $6.5 billion during Q1 2024, and its lowest value of $1.3 billion during Q3 2023.
- Over the past 5 years, Roivant Sciences' median Equity Average value was $2.3 billion (recorded in 2021), while the average stood at $3.5 billion.
- Per our database at Business Quant, Roivant Sciences' Equity Average plummeted by 3709.38% in 2022 and then soared by 33144.03% in 2024.
- Roivant Sciences' Equity Average (Quarter) stood at $2.3 billion in 2021, then crashed by 37.09% to $1.5 billion in 2022, then soared by 168.94% to $4.0 billion in 2023, then soared by 40.53% to $5.6 billion in 2024, then fell by 12.02% to $4.9 billion in 2025.
- Its Equity Average was $4.9 billion in Q4 2025, compared to $4.8 billion in Q3 2025 and $5.0 billion in Q2 2025.